by Allison C Nugent PhD | Mar 9, 2021 | Uncategorized
Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder Presented on Tuesday 9th March 2021 12.30pm EST; 5.30pm UK Lundin NB, Sepe-Forrest L, Gilbert JR, Carver FW, Furey ML, Zarate CA Jr, Nugent AC. J Affect Disord. 2021 Jan...
by Torsten Passie PhD, MD | Feb 23, 2021 | Uncategorized
Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers Presented on Tuesday 23rd February 2021 12.30pm EST; 5.30pm UK Torsten Passie, Hans-Anton Adams, Frank...
by Josh Siegel MD | Feb 9, 2021 | Uncategorized
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression Presented on Tuesday 9th February 2021 12.30pm EST; 5.30pm UK Siegel JS, Palanca BJA, Ances BM, Kharasch ED, Schweiger JA, Yingling MD, Snyder...
by Adriana Feder | Jan 12, 2021 | Uncategorized
An RCT of repeated ketamine administration for chronic post-traumatic stress disorder Presented on Tuesday 12th January 2021 12.30pm EST; 5.30pm UK Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Bevilacqua...
by Christine Ann Denny, PhD | Dec 22, 2020 | Uncategorized
Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine. Presented on Tuesday 22nd December 2020 12.30pm EST; 5.30pm UK Chen BK, Luna VM, LaGamma CT, Xu X, Deng SX, Suckow RF, Cooper TB, Shah A,...
by Roger S McIntyre MD | Dec 8, 2020 | Uncategorized
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence Presented on Tuesday 8th December 2020 12.30pm...
